Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases Cover

.blurhash-client-img { display: none !important; }

Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases

Radiology and Oncology

Volume 54 (2020): Issue 1 (March 2020)

By: Katja Goricar, Viljem Kovac, Metoda Dodic-Fikfak, Vita Dolzan and Alenka Franko

Open Access

|Mar 2020

Authors

Katja Goricar

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Viljem Kovac

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Metoda Dodic-Fikfak

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Clinical Institute of Occupational Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia

Vita Dolzan

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Alenka Franko

alenka.franko@siol.net

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Clinical Institute of Occupational Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2020-0011 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 86 - 95

Published on: Mar 7, 2020

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

malignant mesothelioma,

asbestos-related disease,

soluble mesothelin-related peptides,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2020 Katja Goricar, Viljem Kovac, Metoda Dodic-Fikfak, Vita Dolzan, Alenka Franko, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 54 (2020): Issue 1 (March 2020)Next article